Skip to main content
. 2007 Mar 12;78(10):1056–1063. doi: 10.1136/jnnp.2006.099424

graphic file with name jn99424.f4.jpg

Figure 4 Categorical analysis of the Clinician Interview Based Impression of Change incorporating caregiver information: patient improvement in the intention to treat population administered rivastigmine twice (BID) or three time (TID) daily, or placebo (PBO). *p<0.05, **p = 0.001 vs placebo. p Values based on pairwise Mantel–Haenszel tests.